Literature DB >> 33283635

Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study.

Daniel Gallacher1, Peter Kimani1, Nigel Stallard1.   

Abstract

Extrapolations of parametric survival models fitted to censored data are routinely used in the assessment of health technologies to estimate mean survival, particularly in diseases that potentially reduce the life expectancy of patients. Akaike's information criterion (AIC) and Bayesian information criterion (BIC) are commonly used in health technology assessment alongside an assessment of plausibility to determine which statistical model best fits the data and should be used for prediction of long-term treatment effects. We compare fit and estimates of restricted mean survival time (RMST) from 8 parametric models and contrast models preferred in terms of AIC, BIC, and log-likelihood, without considering model plausibility. We assess the methods' suitability for selecting a parametric model through simulation of data replicating the follow-up of intervention arms for various time-to-event outcomes from 4 clinical trials. Follow-up was replicated through the consideration of recruitment duration and minimum and maximum follow-up times. Ten thousand simulations of each scenario were performed. We demonstrate that the different methods can result in disagreement over the best model and that it is inappropriate to base model selection solely on goodness-of-fit statistics without consideration of hazard behavior and plausibility of extrapolations. We show that typical trial follow-up can be unsuitable for extrapolation, resulting in unreliable estimation of multiple parameter models, and infer that selecting survival models based only on goodness-of-fit statistics is unsuitable due to the high level of uncertainty in a cost-effectiveness analysis. This article demonstrates the potential problems of overreliance on goodness-of-fit statistics when selecting a model for extrapolation. When follow-up is more mature, BIC appears superior to the other selection methods, selecting models with the most accurate and least biased estimates of RMST.

Entities:  

Keywords:  Monte Carlo simulation; cancer; extrapolation; health technology assessment; survival analysis

Year:  2020        PMID: 33283635     DOI: 10.1177/0272989X20973201

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

1.  A progressive three-state model to estimate time to cancer: a likelihood-based approach.

Authors:  Eddymurphy U Akwiwu; Thomas Klausch; Henriette C Jodal; Beatriz Carvalho; Magnus Løberg; Mette Kalager; Johannes Berkhof; Veerle M H Coupé
Journal:  BMC Med Res Methodol       Date:  2022-06-27       Impact factor: 4.612

2.  Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study.

Authors:  Jaclyn M Beca; Kelvin K W Chan; David M J Naimark; Petros Pechlivanoglou
Journal:  BMC Med Res Methodol       Date:  2021-12-18       Impact factor: 4.615

3.  An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial.

Authors:  Mathyn Vervaart; Mark Strong; Karl P Claxton; Nicky J Welton; Torbjørn Wisløff; Eline Aas
Journal:  Med Decis Making       Date:  2021-12-30       Impact factor: 2.749

4.  Comparison of prediction accuracies between two mathematical models for the assessment of COVID-19 damage at the early stage and throughout 2020.

Authors:  Hua-Ying Chuang; Tsair-Wei Chien; Willy Chou; Chen-Yu Wang; Kang-Ting Tsai
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

5.  Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations.

Authors:  Daniel Gallacher; Peter Kimani; Nigel Stallard
Journal:  Pharmacoeconomics       Date:  2021-09-28       Impact factor: 4.981

6.  Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network.

Authors:  Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Michael J Crowther; James R Carpenter; Neil Hawkins
Journal:  Stat Methods Med Res       Date:  2022-01-19       Impact factor: 2.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.